Mechanistically, Lmdd-MPFG activates the NF-κB signaling pathway of tumor-associated macrophages, affects the level of p62, and activates autophagy, enabling the tumor-center T cells to restore their sensitivity to anti-PD-L1 immunotherapy105. This evidence concerns the gene SQSTM1 and neoplasm.